Literature DB >> 8005064

[Combined conservative treatment of localized stomach lymphoma].

R Sonnen1, A Calavrezos, H A Grimm, R Kuse.   

Abstract

In a twelve-year period (1980-1992) 23 patients (9 men, 14 women; mean age 65 [25-82] years) with malignant non-Hodgkin lymphoma of the stomach, in localized stage I or II (Ann Arbor classification), were given chemo- and radiotherapy without preceding operation. The results were compared with those of a group of 34 patients (19 men, 15 women; mean age 55 [17-77] years) who had been admitted during the same period, having first been treated by surgical resection and most of them additionally by chemo- and/or radiotherapy. Three not previously operated patients with inadequate response to chemotherapy subsequently underwent laparotomy and remained in remission after further treatment. There was in each group one fatal recurrence. Five-year total probability of survival in the operated and non-operated groups was 90% and 92%, respectively; five-year total recurrence-free probability was 88% and 86%, respectively. There were no cases of severe bleeding or perforation. These results demonstrate that conservative management of localized gastric lymphoma by combined chemo- and radiotherapy does not bring about a rise in recurrence rate and does not seem to be inferior to surgical treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8005064     DOI: 10.1055/s-2008-1058772

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  [Primary gastric lymphoma].

Authors:  P R Verreet; W U Schmidt; F P Müller
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

2.  Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey.

Authors:  Bulent Eser; Bunyamin Kaplan; Ali Unal; Ozlem Canoz; Fevzi Altuntas; H Ismail Sari; Ozlem Er; Metin Ozkan; Can Kucuk; Makbule Arar; Sebnem Gursoy; Mustafa Cetin
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

Review 3.  Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma.

Authors:  Daniel Rolf; Gabriele Reinartz; Stephan Rehn; Christopher Kittel; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.